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The immunocompetent cells that can recognize foreign structures by their own
actively synthesized antigen-binding receptors are the lymphocytes (1). Two
major groups oflymphocytes exist, with separate functionsandwithoutability to
transform into each other (2, 3). One group is called T lymphocytes, due to their
dependence on the presence ofthe thymus for development (2). The second group
of cells are called B lymphocytes, after the bursa of Fabricius in birds, where
maturation of these B cells do occur (3). T lymphocytes are responsible for the
major part of so called cell-bound immune reactions, whereas B lymphocytes pro-
duce conventional immunoglobulin antibodies.
The chemical structure of the antigen-binding receptors on the B lymphocytes is
generally considered to be that of a classical immunoglobulin, with minor modifications as
to make the molecule surface-attached (4). With regard to the antigen-binding receptors
on T lymphocytes opinions do vary considerably as to the nature of the receptor, and
classical immunoglobulins (5, 6) as well as molecules, determined by genes associated with
the loci determining the major histocompatibility antigens of the species (7, 8), have been
implied. Most workers have failed, by classical means, to detect significant amounts of
immunoglobulin on the surface of T lymphocytes (9-11).
One approach to the study of the molecular basis of the receptors on T lymphocytes
would be to use anti-idiotypic antibodies directed against the products of B lymphocytes,
that is against antibodies specific for a particular antigen determinant. If such
antiantibodies would have a detectable significant impact on T lymphocytes capable of
reacting with the same antigen, this would strongly suggest that B and T lymphocytes use
the same variable set of genes for the creation of antigen-binding sites on their receptors.
Indications that such anti-idiotypic antibodies will have the expected impact on the
relevant T lymphocytes have come from work in systems using an F, hybrid to parent
combination taking advantage of the immunogenetical filter in the production of such
specific antiantibodies (12, 13) . Using this system substantial amounts of data have been
accumulated to suggest that B and T lymphocytes directed against the same alloantigenic
determinants may share idiotypic determinants (14-17). Final proof for such an identity is
still lacking, however, as in most tests either the lymphocyte populations or the antiserum
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used for immunization might have been contaminated with products from the other
lymphocyte group.
In a previous set of articles we accumulated sizeable amount of results, indicating that
anti-idiotypic antibodies produced in an F, hybrid rat against antibodies produced in one
parental strain against the alloantigens of the other strain, will inhibit the T lymphocytes
of the genotype of the antiserum donor to function in the relevant, cell-bound immune
reactions (15-17) . In radioimmunoassays, however, we were only able to show that such F,
antibodies would react in a detectable manner with B lymphocytes of the relevant strain
(16, 17) . As we considered this to be a matter of sensitivity of the test or quality of
antibodies induced we have now tried and found it possible to obtain extremely
high-titered antibodies produced in F, hybrid rats against T lymphocytes of one of the
parental strains. Such antisera were found to react with highly purified IgG alloanti-
bodies, produced in the T donor strain against alloantigens of the other parental strain.
They were also found capable of reaction with the relevant immunocompetent normal
parental T lymphocytes. Absorption experiments were then performed that showed that
highly purified IgG alloantibodies could remove the reactivity of the F, anti-idiotypic anti-
bodies against the relevant "pure" parental T lymphocytes and vice versa.
Thus the results obtained all directly demonstrate that B and T lymphocytes di-
trected against the same antigenic determinants have antigen-binding receptors,
which are similar or identical with regard to their antigen-binding sites as judged
by their shared idiotypes.
Animals.
￿
Rats of the inbred strains Lewis (L) (Ag-b'), DA (Ag-B'), and BN (Ag-Be) as well as F,
hybrids between these strainswere domestically raised and maintained. Either adultmale or female
rats were used within an experiment.
RatLymphocyte Preparations
Material and Methods
SINGLE LYMPHOID CELL SUSPENSION.
￿
Thesewere done from spleens and lymphnodesaccording to a
standard procedure (18). Red cells were lysed by incubation in 0.84% NH,Cl for 8 min at room
temperature. Lymphoid cells were washed twice with Eagle's basal medium (BME)' containing 5%
heat-inactivated fetal calf serum (FCS). The cell viability wasjudged by trypan-blue exclusion.
PREPARATION OF RAT T LYMPHOCYTES . This was done as already described by using Degalan V-26
beads coated with rat gamma globulin and rabbit antirat gamma globulin (16). Such T-cell prep-
arations showed normally less than 2% B-cell contamination as judged by autoradiography using
"'iodine-labeled rabbit antirat gamma globulin or by immunofluorescence technique using rabbit
antirat gamma globulin and FITC-coupled goat IgG antirabbit IgG.
PURIFICATION OF RAT B LYMPHOCYTES. For this a rabbit antirat T-lymphocyte serum was used in a
cytolytic assay. A rabbit was inoculated with 5 x 108 peripheral purified ratT lymphocytes twice at
2-wk intervals and bled 1 wk after last injection. The serum was heat-inactivated andthen absorbed
extensively with rat liver cells until a serum was produced that killed 30-40% of rat spleen cells and
60-70% of ratlymphnode cells in thepresence of guinea pig complement.The killing wasat thesame
plateau level over several twofold dilutions up to 1:500 serum dilution. For purification of spleen B
cells, cells were incubated with the antiserum at 4°C for 1 h whereafter guinea pig complement was
added and the suspension was incubated at 37°C for 40 min (using dilutions of antisera and
complement as to achieve the aboveindicated percentual lysisof spleen cells) . Cellswere then filtered
through sterile gauze to remove debris and dead cellsand washed threetimes. Such cell suspensions
were enriched for Ig surface-positive cells to more than 90% positive cells.
'Abbreviations used in this paper: BME, Eagle's basal medium; FCS, fetal calf serum; MLC,
mixed leukocyte culture ; PBS, phosphate-buffered saline.HANS BINZ AND HANS WIGZELL
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Production of Rat Antisera
PRODUCTION OF ALLOANTISERA .
￿
Rat alloantisera of specificity Lewis anti-DA and DA anti-Lewis
were raised by full thickness skin grafts from one strain to another (18). 3 wk after a single skin graft
animalswere bled and the sera heat-inactivated at 56°C for 30 min, Millipore filtered, andstored at
- 20°C. Such alloantisera showed titers between 1:2,048 and 1:8,192 as measured in a hemagglutina-
tion assay described elsewhere (19) .
PRODUCTION OF ANTI-IDIOTYPIC ANTISERA.
￿
SeeResults.
Purification of Rat IgG. This was done as described previously (13) . Briefly, the gamma globulin
fraction was precipitated with saturated (NH,),SO, or by dialysis against 18%and 15%Na,SO,. The
IgG fraction was then purified on DEAF-cellulose. Such preparations showed asingle IgG peak on a
calibrated G-200 column. In immunoelectrophoresis the preparations showed a single IgGprecipita-
tion line against arabbit antiserumagainst wholeratserum.
Graft-us.-Host Reactions.
￿
These were done in 5- to 8-wk old F, rats as described previously (15).
4 x 108 viable parental lymphocytes in 0.1 ml BME were injected into each foot pad. Animalswere
killed 7 days later and the lymph nodes were excised and weighed (20).
Mixed Leukocyte Culture (MLC). Rats were anesthesized with ether and then killed by cervical
dislocation and their spleensland lymph nodes aseptically teased with forceps in petri dishes
containing RPMI 1640 (Flow Laboratories, Inc., Rockville, Md.) complemented with glutamin (2.5
mg/ml), 100 IU of penicillin, 100 ug of streptomycin, and 5% FCS (Flow Laboratories). The
undissociated cells were allowed to settle for 5 min at 4°C. The single cell suspension was washed
twice with the same medium. Stimulator cells were adjusted to 1 x 108 cells per ml and were
irradiated with 2,000 rad from an X-ray machine. The cells were washed again andadjusted to 7.5 x
106 per ml. Untreated responder cells were adjusted to 1.5 x 10' cells per ml. 5 x 10' pelleted
responder cells were incubated with 100t,l of 1:2 diluted anti-idiotypic or normal F, serumfor60 min
at 4°C after which guinea pig complement (absorbed with agarose, 80 mg/ml serum) was addedto a
final dilution of 1:3. After a further incubation for 40 min at room temperature, cells were washed
twice and finally adjusted to 1.5 x 10' viable cells per ml. Both the F, anti-idiotypic and thenormal
F, serum were previously absorbed with 1 x 10'(Lewis x DA)F, lymphoid cells perml serum.
The one-way mixed leuckoyte culture (MLC) was performed in Cooke round bottom microtiter
plates (Cooke Laboratory Products, Div. Dynatech Laboratories, Alexandria Va.) using 1.5 x 108
respondercellsand 0.75 x 106 stimulator cellsin a total volof 0.2 ml. The culture medium wasRPMI
1640 (Flow Laboratories) complemented with glutamin, penicillin and streptomycin (see above) and
5% (Lewis x DA)F, normal rat serum previously absorbed with 1 x 10' (Lewis x DA)F, lymphoid
cells per ml serum. Control cultures contained responder cells or stimulator cells alone in
concentrations as in the one-way MLC. All cultures were pulsed for 16 h on day 3 with 2 juCi of
['H-Jthymidine (Radiochemical Centre, Amersham) with aspec actof 5 Ci per mmol in 20,ul culture
medium without normal rat serum. On day 4 the cellswere harvested using aSkatron collectorand
washed on glassfiber filters. The filters were dried and placed into plastic scintillation vials. All
samples were counted in 3 ml scintillationfluid in an Intertechnique SL 30 liquid scintillation spec-
trometer.
Immunabsorbeas Technique.
￿
IgG preparations from Lewis anti-DA alloantibodies, Lewis, and
(Lewis x DA)F, normal sera were coupled to CnBr-activated Sepharose 4 B (Pharmacia Fine
Chemicals, Uppsala, Sweden) using carbonate buffer pH 9.0. Afterincubation for4h at room temper-
ature the beads were washed once with coupling buffer followed by an incubation with 1 M ethanola-
min pH 8.0 for 2 h at room temperature. Beads were then washed with isotonic glycin-HCI buffer pH
2.8 containing 2 M NaCl followed by 0.1 M carbonate buffer pH 8.0 containing 1 M NaCl. This was
done three times in a cyclic way. The beads were finally washed with phosphate-buffered saline
(PBS) and filled into plastic syringes and washed again with excess PBS. Serum to be analyzed was
passed over the column and washed out with PBS. Theeluate was collected andpassed againthrough
the same column and finally sterile filtered. Columnswere washed with excess PBSuntil the washing
fluid contained less than 10 lug per ml of protein. Absorbed material was then eluted with isotonic
glycin-HCI buffer pH 2.8 containing 2 M NaCl. The eluate was neutralized immediately, dialyzed
against PBSandconcentrated by vacuum dialysis andfinallysterile filtered.
Indirect Radioimmunoassay
USING 1261-RADIOLABELED RABBIT ANTI-RAT IG.
￿
Normally, I X 10' purified ratT lymphocytes were
distributed into two or three parallel 2-ml plastic tubes. To the cell- pellet 50,1 of 1:10 diluted (oras200
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indicated in the tables) serum was added. The mixture was incubated for 1 h at 4°C. Cells were then
washed three times with BME containing 5% FCS. 0.1 ml of 1251-radiolabeled rabbit IgG antirat Ig
(spec act 1 mCi per mg protein) corresponding to about 1-2 x 10' cpm Of 1251 were added to the cell
suspension and incubated for 1 h at 4°C after which the cells were washed five times. After the final
wash the cells were transferred into new plastic tubes and counted for 1 min in a Intertechnique CG
30 automatic gammaspectrometer.
For quantitation of many samples the test was modified in the following manner (22). 1 x 101
lymphoid cells in 25 Al were distributed in round bottom microtiter plates (Cooke Laboratory), 25 dal
of 1:10 diluted (or as indicated) serum was added into each well and the plates gently shaked and
incubated for 1 h at 4°C. The plates were then centrifuged for 10 min at 1,500 rpm in an X-3 Wifug
(Winkelcentrifug, Stockholm) centrifuge in special holders fitting the microtiter plates. The
supernates were smashed out into a sink and the cells resuspended with BME; cells were washed
three times. 25 gl of 1251-labeled rabbit IgG antirat Ig (corresponding to about 2.5-5 x 105 cpm) were
then added into each well. After incubation for 1 h at 4°C the cells were washed again three times as
described above. Finally the cells were transferred into plastic tubes for gamma counting.
USING 1251-LABELED PROTEIN A FROM STAPHYLOCOCCUS AUREUS. Protein A from Staphylococcus
aureus is amolecule with specificity for Fc of most mammalian IgG classes (23). It can be iodinated and
used as asensitive probe for cell-bound IgG molecules (21). The procedure was identical to the second
one described previously for radiolabeled rabbit antirat Ig, andhasbeen described previously in detail
(21) .
Passive Hemagglutination Assay.
￿
This was done as described elsewhere (24) . 300 kg IgG from
relevant rat serum was dissolved in 200 gl saline. 10 gl of 0.07% CrCl, solution and 100 ul of 50%,
five times washed sheep red blood cells (SRBC) were added and the suspension well mixed. The CrCl,
wasdissolved in saline andwas kept half an hour at room temperature before used. After incubation of
The elegant technical assistance of Berit Olsson, Ann Sjolund, and Lisbeth Ostberg is gratefully
heat-inactivated FCS. After the final wash the coated SRBC were adjusted to afinal concentration of
0.2% with saline containing 5% FCS. 25 Al of 0.2% coated SRBC were incubated with 25 jut of
anti-idiotypic or normal sera dilutions for 1 h at room temperature followed by 2 h at 4°Cor overnight
at 4°C in V-bottom micro titer trays (BIO-cult, Linbor, IS MVC 96). Before used in this assay the
anti-idiotypic sera were absorbed once with one tenth (vol/vol) of packed SRBC . As controls,
uncoated SRBC or SRBC-treated with CrCl, only were used.
Results
(DA x Lewis)F, Hybrid Rats Inoculated with Parental T Lymphocytes
Produce Antibodies Against Idiotypic Determinants on Relevant Parental
Alloantibodies. Adult F, hybrid rats were inoculated intraperitoneally with
graded doses of normal parental T plus B lymphocytes (spleen and lymph node
cells) or normal T lymphocytes (spleen and lymph node cells that had been
filtered through an anti-Ig column). They would then be expected to produce
antibodies against cell-bound receptors, present on the inoculated cells and with
specificity for alloantigens of the other parental strain (12). At various times
thereafter the animals were bled and their sera analyzed for possible content of
antialloantibodies in the indirect hemagglutination assay. Representative results
of such experiments are shown in Table I and indicate that theF, hybrid rats will
make such antibodies [as shown before (13, 16)] . The best way to obtain
high-titered antialloantibodies was to inoculate column-purified parental T
lymphocytes, whereas the presence of parental B lymphocytes, if anything,
seemed to have an inhibitory effect. The present results would seem to indicate
that either T and B lymphocytes directed against the same alloantigens do share
idiotypic determinants or, alternatively a few contaminating B cells amongst the
inoculated parental T cells do carry the antigen-binding receptors responsible for
the induction of these anti-idiotypic determinants.HANS BINZ AND HANS WIGZELL
TABLE I
Induction of Antialloantibodies Reactive with Alloantibody IgG of Relevant Specificity in
(DA x Lewis)F, Rats Inoculated with DA or Lewis Lymphocytes
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All sera tested against SRBC coated with IgG from DA, Lewis or (DA x Lewis)F, normal sera as well as against
SRBC coated with IgG from DA anti-Lewis or Lewis anti-DA immune sera. All sera were preadsorbed with SRBC
before testing. Only groups where agglutination occurred are indicated in the table. Starting size of experimental
groups normally five animals per group.
The rest of the present article we will use to try to prove that in fact T and B
lymphocytes directed against the same alloantigens do have shared (or identical)
antigen-binding receptors as judged by the use of anti-idiotypic antisera . For this
purpose we inoculated a largenumber of F, hybrid rats intraperitoneally with 2 x
107 DA or Lewis column-purified T lymphocytes once every week and tested the
antisera obtained at various time intervals for anti-idiotypic antibodies in the
agglutination assay. A pool of unusally high-titered anti-idiotypic antibodies
produced against Lewis T lymphocytes was obtained by such a procedure. Most
of the present results to be described were carried out with this single, large pool
of well-defined antibodies. This serum pool will be called 1003, and wasobtained
from a group of five (DA x Lewis)F, rats bled after inoculation 4-7 times with 25
x 106 Lewis T lymphocytes intraperitoneally, The pool was heat-inactivated at
56°C for 30 min, and was then adsorbed with normal (DA x Lewis)F, hybrid
spleen and lymph node cells to remove possible autoimmune antibodies (25) .
Characteristics of the (DA x Lewis)F, Serum 1003 Obtained by Immunization
with Lewis T Lymphocytes
BINDING TO LEWIS-ANTI-DA 19G ALLOANTIBODIES . As stated before the 1003
serum was selected for its unusually high titer of anti-(Lewis anti-DA) anti-
bodies . The titers and demonstration of the anti-idiotypic nature of the 1003
serum is shown in Table II. As seen, not only had the 1003 serum an extremely
high titer against sheep erythrocytes coated with IgG from Lewis anti-DA
alloantiserum (216 in titer), but it was also precipitating in gel against such
alloantisera . A similar precipitating capacity of antialloantibodies has been
reported before (26). As the 1003 serum in the hemagglutination or gel-diffusion
tests with IgG did not react with any other normal or immune serum than the
Lewis anti-DA serum (e.g. no reaction with Lewis anti-BN alloantisera) we
conclude that this serum must contain a high concentration of true anti-idiotypic
antibodies with specificity forLewis antibodies directed against DA alloantigens.
BINDING TO NORMAL LEWIS T AND B LYMPHOCYTES. The 1003 serum was now
tested for its capacity to react with normal lymphocytes from various rat strains
Exp. Immunizing cells Targetcells
4
Days
5
postimmunization
7 10 15
1 DA, T + 13,5 x 10' SRBC, DA anti-Lewis IgG 3.510.3 5.810.5 6.511.0 6.311.0
2 DA, T + B, 2.5 x 10' SRBC, DA anti-Lewis IgG 2.0+0.0
DA, T 2.5 x 10' 3.0+0.4
3 Lewis, T + B, 5 x 10' SRBC, Lewis Anti-DA IgG 3.0+1 .0 2 .7+0.9 4.0+1.5 3.5+0.5
4 Lewis, T + B, 2.5 x 10' SRBC, Lewis Anti-DA IgG 2.4+0.5
Lewis, T 2.5 x 10' 7.0+1.1202
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or F,-hybrids using the indirect radioimmunoassays as described in the methods
section. Of the tested strains, only Lewis normal lymphocytes could be shown to
bind 1003 antibodies as seen in Table III. When the distribution of bindingLewis
lymphocytes was analyzed as to T or B type or to organ distribution sizeable,
TABLE II
Presence ofAnti-Idiotypic Antibodies with Specificity forLewisAnti-DA Alloantibodies
in 1003 Serum
TABLE III
Uptake of Serum 1003 by Lewis Spleen Cells and Lewis Purified
T Cells as Measured by 12'I-labeled Rabbit Antirat Ig
* S denotes a mixture of spleen and lymph node cells; T denotes T lym-
phocytes prepared by fractionation of spleen and lymph node cells over
anti-Ig bead columns; Thp denotes thymocytes which have been passed
over anti-Ig columns.
$Input per tube: 5 x 105 cpm of [I251]rabbit antirat Ig.
Line
Lymphoid cells* Incubated with :
Uptake of [1251]rabbit
antirat Ig$ (Mean cpm
of quadruplicates t SE)
LS Serum 1003 16.878 f 1.274
LS N rat S 7.712 t 1.018
LT Serum 1003 12 .756 t 700
LT N rat S 6.869 f 534
LThP Serum 1003 1 .269 106
LThP Nrat S 1.105 f 44
DAS Serum 1003 9.119 t 1.513
DAS Nrat S 8.578 t 489
DA T Serum 1003 6.350 1: 457
DA T Nrat S 5.580 f 552
DA Th p Serum 1003 566 t 53
DA Th p Nrat S 498 t 55
F, S Serum 1003 4.622 f 306
F, S N rat S 4.818 f 112
F, T Serum 1003 3.346 t 490
F, T N rat S 3.927 t 523
F,Thp Serum 1003 528 f 41
F,Thp N rat S 415 +33
BN pT Serum 1003 4.196 t 58
BN T N rat S 5.393 _±:78
BNThp Serum 1003 480 f 42
BNThp N rat S 342 t 28
Indirect hemagglutination
Target Titer
Geldiffusion
Target serum
SRBC-Lewis normal IgG Neg Lewis normal
SRBC-Lewis anti-DA IgG 2'e-2'B Lewis anti-DA
SRBC-Lewis anti-BN IgG Neg Lewis anti-BN
SRBC-DAnormal IgG Neg DA normal
SRBC-DAanti-Lewis IgG Neg DA anti-Lewis
SRBC-(DA x L)F, normal IgG Neg (DA x L)FnormalHANS BINZ AND HANS WIGZELL
specific binding toboth T and B lymphocytes was observed asshown in Tables III
and IV. The binding to normal Lewis thymocytes, on the other hand, was
insignificant. It should be noted that some of the tests in Table IV were
performed using radiolabeled protein A from Staphylococcus, demonstrating
that the 1003 serum contained IgG anti-idiotypic T-cell-reactive antibodies. The
fact that the indirect radioimmunoassay even did function when using a mixture
of T and B lymphocytes as targets (thus having a highly significant background
noise due to the binding to surface Ig on normal B lymphocytes) would indicate a
TABLE IV
Capacity of Lewis T or B Lymphocytes to Bind (DA x L)F,
anti-Lewis T Antibodies
* Lewis T cells were prepared by fractionation of spleen and lymph node
cells over anti-Ig bead columns . B cells were produced by cytolysis of T
cells by a rabbit antirat T-cell serum in presence of complement. Purity
with regard to T and B respectively exceeded 95%.
$ Directly 1251-labeled or unlabeled F, anti-Lewis Tserum wasused. When
1251-labeled, the IgG fraction of the antiserum was used. Input per well:
3 x 105 cpm.
§ + denotes secondary addition of (1251]protein A to the test. Input per
well: 5 x 101 cpm.
Mean t BEM. Triplicates. Italicized figures denote significantly in-
creased specific binding compared to DA cell controls.
2 Binz, H., and H. Wigzell. Manuscript in preparation.
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high number of idiotype-positive cells in the present system as subsequently
found to be true .2
PROOF THAT THE BINDING OF THE 1003 ANTIBODIES OCCURS WITH RECEPTORS
PRESENT ON NORMAL LEWIS T LYMPHOCYTES AND WITH SPECIFICITY FOR DA ALLO-
ANTIGENS AND NOT WITH ALL LEWIS T CELLS. We have previously found that F,
hybrid antisera produced against parental alloantisera in rats, in the presence of
complement, will inhibit the capacity of the relevant parental T lymphocytes to
function in a given graft-vs.-host (GVH) reaction (17). We now first tested if the
Cells* Antiserum$ ('25I]pA§ Mean t SE11
Lewis T [1251]F, anti-Lewis T - 6.399 t 256
Lewis T F, anti-Lewis T + 1 .074 t 78
Lewis T F, normal + 222 t 15
Lewis B 11"IIF, anti-Lewis T - 11 .826 t 650
Lewis B F, anti-Lewis T + 26.325 t 1 .161
Lewis B F, normal + 12.445 t 981
DA T ("'I]F, anti-Lewis T - 2.098 1283
DA T F, anti-Lewis T + 280 t 26
DA T F, normal + 342 t 22
DAB [1251 [F, anti-Lewis T - 1.870 t 261
DA B F, anti-Lewis T + 12.075 t 639
DAB F, normal + 14.349 t 137204
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1003 serum could selectively inactivate Lewis T lymphocytes from participating
in immune reactions against DA alloantigens, whilst sparing the reactivity
against alloantigens of other strains intact. Two test systems were used: GVH
reactions as measured by the local popliteal lymph node assay and the MLC
system. Examples of the results obtained in the two systems are shown in Table
V (see also Table VII) and demonstrate clearly that the 1003 serum contains anti-
bodies specific for receptors on those Lewis T lymphocytes that can react with
DA alloantigens. Thus, a close to complete inhibition of the reactivity against DA
alloantigens was observed in both systems, whereas reactivity against BN was
left largely untouched.
TABLE V
Serum 1003 Specifically Eliminates Lewis Anti-DA GVH-Reactive T Cells
* 5 x 106 spleen and lymph node cells were injected into each foot pad.
$Mean weights of four nodes (mg).
§ Not significantly different from 0.
11 Significantly different from 0 (P < 0.01).
PROOF THAT THE 1003 ANTIBODIES DIRECTED AGAINST IDIOTYPIC DETERMINANTS ON
T LYMPHOCYTES AND THOSE DIRECTED AGAINST THE IDIOTYPE-POSITIVE LEWIS-ANTI-
DA Ig'G ALLOANTIBODIES ARE THE VERY SAME ANTIBODY MOLECULES . The antibodies
in the 1003 that are capable of reaction with those Lewis T lymphocytes that
are immunocompetent to react against DA alloantigens and those 1003 anti-
bodies in the 1003 that are capable of reaction with those Lewis T lymphocytes
that are immunocompetent to react against DA alloantigens and those 1003 anti-
bodies that react with Lewis anti-DA IgG antibodies had now both been shown to
be idiotypic. It now remained to finally demonstrate that the normal Lewis T
lymphocytes with receptors for DA alloantigen did share idiotypic determinants
with the Lewis anti-DA alloantibodies produced by B cells ; that is, to prove
identity or similarity between the antigen-binding sites of the two groups of
reactive molecules . Two approaches were used. In the first, highly purified IgG
was produced from Lewis anti-DA immunserum (see Methods) and covalently
Cells
in-
jected*
Host
Injected cells
treated with:
Mean of
"Lewis"
lymph
node
weights$
Mean of
"DA"
lymph
node
weights$
Mean of
"BN"
lymph
node
weights$
Mean log
ratio f SE
L (L x DA)F, (L x DA)F, NS + C' 70.7 f 8.6 -0.01 t 0.02§
DA (L x DA)F, NS + C' 70.2+-7 .6
L (L x DA)F, Serum 1003 + C' 11 .2 f 0.9
0.81 t 0.021
DA Serum 1003 + C' 73.2 t 5.03
L (L x BN)F, (L x DA)F, NS + C' 33.7 t 5.3 -0.01 t 0.05§
BN (L x DA)F, NS + C' 32.2 f 2.5
L (L x BN)F, Serum 1003 + C' 31.5 t 3.7 -0.00 + 0.07§
BN Serum 1003 + C' 31 .9 t 4.3HANS BINZ AND HANS WIGZELL
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linked to Sepharose beads. Such immunosorbant columns (and controls) were
now analyzed for their capacity to remove from the 1003 serum the capacity to
react with Lewis T lymphocytes as measured in radioimmunoassays or GVH or
MLC reactions. The tests were performed testing both the immunosorbent
column passed 1003 serum as well as the adsorbed and at low pH eluted 1003
material for inhibitory or binding capacity. Results of such experiments are
shown in Tables VI, VII and VIII, and demonstrate the selective capacity of
highly purified Lewis anti-DA IgG columns to remove in a recoverable form the
1003 antibodies with capacity to react with normal Lewis anti-DA-reactive T
TABLE VI
Capacity ofLewis Anti-DA Immunoabsorbens to Remove (Lewis x DA)F, Anti-Lewis T
Anti-Idiotypic Antibodies
Uptake of [12511
Lymphoid
￿
rabbit antirat Ig
cells
￿
Mean cpm of trip-
licates t SE*
* Input per well: 2 x 108 cpm of ["I]rabbit antirat Ig.
cells . The included controls demonstrated the Ig nature of the inhibitory capacity
of the 1003 serum . Furthermore, the specificity of 1003 removing capacity of the
IgG Lewis anti-DA column was further proven by the failure of such columns to
remove DA antisheep red blood . cell antibodies, thus also excluding the
possibility that any anti-DA allotype-specific antibodies might have been on the
column . Thus, these data strongly suggest the presence of identical idiotypes on
IgG molecules produced in Lewis B cells against DA alloantigens and on the
antigen-binding surface receptor on normal Lewis T cells with capacity to react
against DA alloantigens.
To further prove this point normal Lewis T or T + B cells were used as specific
immunosorbents to remove from the 1003 serum the antibodies, capable of
agglutinating in the anti-idiotypec agglutination test, erythrocytes coated with
LT Serum 1003 70.074 t2.119
LT NratS 22.367 t 2.026
LT Serum 1003 absorbed on L anti-DAIgG 24.505 t 787
LT Serum 1003 absorbed on Lnormal IgG 51.545 f 6.648
LT Serum 1003 absorbed on (L x DA)F,normal IgG 56.551 t 3.355
LT Serum 1003 boundand eluted from L anti-DAIgG 64.931 t 9.626
LT Serum 1003 boundand eluted from L normal IgG 19.542 t 469
LT Serum 1003 bound andeluted from (L xDA)F, normal IgG 21 .618 t 2.401
DA T Serum 1003 29.271 f 2.819
DA T N ratS 25.444 t 384
DA T Serum 1003 absorbed on Lanti-DAIgG 32.788 t 2.350
DA T Serum 1003 absorbed on Lnormal IgG 28 .713 t 1.164
DA T Serum 1003 absorbed on (L x DA)F,normal IgG 27 .542 t 1.037
DA T Serum 1003 bound and eluted from L anti-DA IgG 25.659 t 304
DA T Serum 1003 bound andeluted from Lnormal IgG 28.245 t 2.537
DA T Serum 1003 bound andeluted from (L x DA)F, normal IgG 25.786 t 2.829206
TABLE VII
Effect of Serum 1003 on the MLC Reaction. Selective Removal of Inhibitory Capacity with L
anti-DA Alloantibody IgG Immunosorbant
SHARED IDIOTYPIC DETERMINANTS ON B AND T LYMPHOCYTES
['H ]Thymidine
* 3 x 106 spleen cells and lymph node cells were injected into each foot pad.
['H]Thymidine ['H]Thymidine
incororationof
￿
incororation of
TABLE VIII
Capacity ofLAnti-DA Alloantibody IgG to Remove Anti-Idiotypic Antibodies from 1003
Serum as Measured by Inhibition of GVH-Reaction
IgG Lewis anti-DA alloantibodies. As seen in Table IX purified Lewis T
lymphocytes were, if anything, better than T+ B cell mixtures in removing such
specific anti-idiotypic antibodies . We could thus conclude that, by all measure-
ments, Lewis normal T lymphocytes, with the capacity to react with the DA
Responder
cells
Target
cells
Responder cells
treated with
incorporation of
mixture. Mean
cpm ofquadru-
plicates + SE
responder cells
alone. Mean
cpm of tripli-
cates + SE
target cells
alone. Mean
cpm of dupli-
cates + SE
L (L x DA)F, 32.933 t 245 1.017 + 84 167 + 11
L " (L x DA)F, NS + C' 32.112 + 145 1.566 + 352 187 + 26
L " Serum 1003 + C' 1 .938 t 29 1.133 + 43 199+2
L " Serum 1003 abs L anti-DA IgG + C' 30.929 t 292 1.006 t 48 179 + 23
L " Serum 1003 abs LNS IgG + C' 1 .680 + 419 1.040 + 62 223 + 41
L " Serum 1003 abs (L x DA)F, IgG + C' 1 .609 + 113 1.015 + 57 244 + 49
L ". Serum 1003 bound and eluted from 3.013 t 273 1.087+72 214 t 102
L anti-DA IgG + C'
L Serum 1003 bound and eluted from 31 .525 + 743 2.037 + 741 249 + 27
LNSIgG + C'
L Serum 1003 bound and eluted from 30.987 + 1.155 1.777 + 373 296 + 65
(L x DA)F, IgG + C'
L (L x BN)F, (L x DA)F, NS + C' 22.857 t 891 1 .814 + 799 252 + 111
L (L x BN)F, Serum 1003 + C" 21.844 + 1.091 1 .007+ 154 366 + 220
DA (L x DA)F, (L x DA)F, NS + C' 30.294 + 528 1 .134+61 195+72
DA (L x RAW, Serum 1003 + C' 29.915 t 257 1 .227 + 81 214 t 35
Cells
in-
jected*
Host Injected cells treated with :
Mean of
"Lewis"
lymph
node
weights*
Mean of
"DA"
lymph
node
weights*
Mean log
Ratio t SE
L, DA (L x DA)F, (L x DA)F, N S + C' 28 .5 3.3 26.4+2.9 -0.0210.02
L, DA Serum 1003 + C' 6.1=1 32.615.6 0.73+0.06
L, DA Serum 1003 abs L anti-DA IgG + C' 27 .7+1 .6 25.0=0.3 -0.0410.02
L, DA Serum 1003 abs L N S IgG + C' 6 .2=0.6 33.6=3 .5 0.7010.07
L, DA Serum 1003 (L x DA)F, N S IgG 4 .1=0.4 33.0=2.2 0.89=0.01
+ C'
L, DA Serum 1003 bound and eluted from 5.1+1 .0 29.7+2.7 0.78=0.09
L anti-DA IgG + C'
L, DA Serum 1003 bound and eluted from 21 .8=1 .0 22.910.7 0.02=0.01
LNSIgG+C'
L, DA Serum 1003 bound and eluted from 26.2=1.2 23.5=1.4 0.05=0.05
F,NSIgG+C'HANS BINZ AND HANS WIGZELL
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TABLE IX
Capacity of Normal Lewis TLymphocytes to Adsorb away Serum
1003 Antibodies as Subsequently Measured in the Indirect
Hemagglutination Assay
* 10' cells of indicated type was added to each hole in the microplate,
whereafter twofold dilutions of 1003 serum was added. Purity of T cells
with regard to B-cell contamination = 98% or more. B-cell contamina-
tion in T + B cell populations = 50-60%. T + B = spleen and lymph
node cells mixture. T = T cells purified out of the T + B population via
passage through anti-Ig columns.
$ Agglutination as assessed against SRBC coated with Lewis-anti-DA IgG
antibodies. Controls including SRBC coated with IgG from normal
Lewis, DA or F, sera as well as IgG from DA-anti-Lewis immune sera
were negative .
strain alloantigens, have receptors with identical idiotypes to the IgG antibodies
that Lewis B cells will produce against the same alloantigens.
Discussion
The aim of the present article is to demonstrate that the antigen-binding
receptors on B and T lymphocytes reactive against the same antigenic determi-
nants do share idiotypic determinants. F, hybrid animals can be immunized
against parental lymphocytes or alloantibodies produced in one parental strain
against alloantigens of the other parental strain. Such antireceptor antisera
made in F, hybrid mice or rats have been found capable of selective interference
with relevant parental lymphocytes as measured by in vitro (12-14, 16, 27) or in
vivo (15, 17, 26-28) tests.
Using radiolabeled F, antialloantibody IgG molecules it was previously found
possible to label parental lymphocytes of the relevant strain (13, 16) . Here, the
presence of idiotypic receptors on normal parental lymphocytes was parallelled
by the selective ability of such lymphocytes to bind in vitro to the relevant
allogeneic monolayer of cells (16, 17) . Although such antialloantibody serum was
found able to selectively interfere with the specific binding to the monolayer of
both B and T lymphocytes (16, 17), in the previous assays only B lymphocytes
could be shown to bind enough radiolabeled anti-idiotypic alloantibody IgG
molecules to allow detection. However, we then favored the interpretation that T
cells as well as B cells should bind in such anti-idiotypic assays, provided the
Exp. Inhibitory cells* Agglutination
titers$
1 Lewis T 25
(Lewis x DA)F, 215
0 216
2 Lewis, T +B 27
Lewis, T 25
(Lewis x DA)F T + B 211
(Lewis x DA)FT
212
213208
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radioimmunoassay became sensitive enough or the anti-idiotypic antibodies had
the relevant specificity. The present results have indeed shown that when F,
hybrids make high-titered antisera against parental T-cell receptors with
specificity for alloantigen of the other parental strain, such sera will now also be
capable of showing directly demonstrable bindingto parental immunocompetent
T lymphocytes carrying such idiotypic, antigen-binding receptors.
A great help in the analysis of anti-idiotypic antibodies produced in F, hybrids
against inoculated alloantiserum, produced in one parental strain against the
alloantigens of the other parental, came with the development of a sensitive
indirect hemagglutination assay to detect such antibodies (24, 26). Taking
advantage of these findings we have been able to confirm and extend the results
previously obtained in the radioimmunoassays and the cellular immune reac-
tions (15-17), and as we believe, to finally prove the existence of shared idiotypic
determinants on antigen-binding receptors on T or B lymphocytes reactive
against the same antigenic determinants. The crucial issue to consider in such
an approach is the purity of the reagents or cells used, as "pure" T lymphocytes
could always be contaminated by a certain low but still decisive number of B
cells (or cytophilic B-cell products) whereas on the other hand, alloantiserum
used in the previous assays might have contained soluble T-cell receptors (12, 14,
16, 17). Our approach in the present article was to immunize F, hybrids with
"pure" parental T lymphocytes, trying to make a pool of high-titered antiserum,
reactive with idiotypic receptors or antibodies with the relevant antigen-binding
specificity. T lymphocytes were used as "antigen" as we had previously had
problems to get high enough titered antisera by the use of injection of
alloantibodies only (16, 17). There are reasons to believe that receptors on
immunocompetent T cells would be most immunogeneic in this system. We
succeeded in producing such high-titered F, antisera using as a screening assay
sheep erythrocytes coated with IgG from relevant immune parental alloan-
tiserum; that is, looking for antibodies directed against idiotypic determinants
present on B-cell products, the IgG molecules. Subsequently we analyzed these
high-titered F, hybrid antisera for their capacity to react in aradioimmunoassay
with normal, parental "pure" T lymphocytes. We could find a nice positive
correlation between anti-idiotypic titer as measured by agglutination of the
alloantibody IgG-coated erythrocytes and the capacity to reactwith the relevant,
parental T lymphocytes.2
We then demonstrated that the binding of F, antibodies as measured in the
radioimmunoassay onto the normal parental T lymphocytes was indeed directed
against idiotypic antigen-binding receptors on a minority of these cells. This was
demonstrated by the capacity of such anti-idiotypic antisera to, in the presence
of complement, selectively abolish the capacity of those parental T lymphocytes
to react against the relevant allogeneic cells as measured in local GVH-reaction
or in vitro MLC, whilst sparing the reactivity of the cell population towards
other, third party allogeneic cells. Furthermore, the strength of the reaction
allowed a direct enumeration of the idiotype-positive T and B cells. 2
The final proof demonstrating identity between the anti-idiotypic antibodies
reactive with the B-cell product, the alloantibodies of IgG type, and those that
react with the idiotypic receptors on the parental T cells came from a series ofHANS BINZ AND HANS WIGZELL
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experiments, where reciprocal adsorptions using highly purified T cells or
IgG-immunosorbents were used to selectively remove the anti-idiotypic anti-
bodies reactive with the "other" idiotype group. Highly purified IgG from the
relevant parental alloantiserum coupled to Sepharose was shown capable of
selective removal of the F, anti-idiotypic antibodies reactive with the relevant
T-cell receptors. As measurements were taken to ensure highestpossible purity of
the IgG alloantibodies before coupling to Sepharose, and contamination with
soluble T-cell receptors for antigen would seem unlikely, unless such receptors
are indeed physically unseparable from conventional IgG molecules. Recipro-
cally, purified parental T cells were capable of selective removal of F, antiall,~-
antibody antibodies as subsequently tested in the hemagglutination assay. Here
the fact that normal purified parental T lymphocytes were seemingly more effi-
cient than a mixture of T and B cells in removing specific anti-idiotypic anti-
bodies as subsequently measured in the hemagglutination assay would strongly
argue against possible B-cell contamination as a cause for the capacity of T cells
to adsorb away these antibodies.
In conclusion, our results demonstrate that T and B lymphocytes directed
against the same alloantigens are using antigen-binding receptors or antibodies
with shared idiotypic determinants. The simplest interpretation of these findings
would be that T and B lymphocytes are indeed using the same set (or subset) of
variable genes to create the antigen-binding area of their respective receptors for
antigen.
Summary
Antigen-binding receptorson T lymphocytes and IgG antibodies with thesame
antigen-binding specificity as the T-cell receptors display shared or identical
idiotypes. This was shown using a system where adult F, hybrid rats between two
inbred strains were inoculated with T lymphocytes from one parental strain.
Such F, hybrid rats produce antibodies directed against idiotypic determinants
present on IgG alloantibodies, produced in the T donor genotype strain and with
specificity for the alloantigens of the other parental strain . The idiotypic nature
of the F, antialloantibody serum against the parental alloantibodies was
demonstrated both by indirect hemagglutination tests or by gel diffusion using
alloantisera with different specificity as targets. Furthermore, theF, anti-T-lym-
phocyte sera could be shown to contain antibodies against idiotypic parental T
lymphocytes as well. This was shown by the capacity of the antisera, in the
presence of complement, to wipe out the relevant parental T-cell reactivity
against the other parental strain (as measured in MLC or GVH) whilst leaving
the T-lymphocyte reactivity against a third, unrelated allogeneic strain intact.
These findings demonstrate that F, hybrid rats inoculated with parental T
lymphocytes make anti-idiotypic antibodies directed against both the T cell
receptors and IgG alloantibodies of that parental strain with specificity for
alloantigens of the other parental strain. In order to prove identity between the
anti-idiotypic antibodies against the B and T-cell antigen-binding molecules the
following experiments were carried out: highly purified IgG from relevant
alloantibody-containing serum in immunosorbent form could be shown to
selectively remove both anti-idiotypic activities from the F, antiserum. Further-210
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more, parental normal T lymphocytes could be shown capable of removing from
the anti-idiotypic antisera all those antibodies that would cause agglutination of
the relevant alloantibody-coated erythrocytes in the indirect agglutination assay.
We would thus conclude that T and B lymphocytes reactive against a given
antigenic determinant use receptors with antigen-binding areas coded for by the
same variable gene subset(s) .
The elegant technical assistance of Berit Olsson, Ann Sjolund, and Lisbeth Ostberg is gratefully,
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Anti-idiotypic antibodies directed against a mouse-antistrepto-
coccal determinant can, if passively administered to normal mice, prime these animals for
helper activity against the streptococcal antigens (K . Eichmann, and K. Rajewsky, per-
sonal communication) . It is possible that these findings have the same meaning as those
results in the present article, that is, that T and B lymphocytes reactive against the same
antigenic determinant may share idiotypic determinants.
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